TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Why Amgen Stock Was Crushing It on Wednesday

The Motley Fool Logo The Motley Fool • •By Eric Volkman
Why Amgen Stock Was Crushing It on Wednesday

Amgen reported strong Q3 2025 financial results, with 12% year-over-year revenue growth to $9.6 billion and raised full-year guidance, leading to an 8.38% stock price increase.

Insights
SYFpB   neutral

Flat revenue performance with a slight stock decline of -3.5%


AMGN   positive

Exceeded analyst expectations with 12% revenue growth, raised full-year guidance, strong performance of key drugs, and positive CEO outlook for future innovation and growth